SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Helius Medical Technologies Inc - Ordinary Shares - Class A

Helius Medical Technologies Inc

HSDT is trending due to positive trial results for its PoNS device in stroke rehabilitation, sparking community excitement about its potential FDA submission under Breakthrough Device Designation. The community is actively discussing the low float and potential for a short squeeze, while some caution about potential dilution. Broader context includes the company's focus on neuromodulation therapies and its existing FDA approval for multiple sclerosis.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia ($NVDA) is trending amid news of China investigating potential antitrust violations related to a past acquisition, sparking concerns about market access and potential penalties. The community debates the significance of this development, with some viewing it as an opportunity to buy the dip while others express concerns about the stock's vulnerability to negative China-related headlines and potential broader market impacts. Despite the uncertainty, some remain optimistic about Nvidia's long-term prospects, citing its leadership in AI and strong fundamentals.

aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.

Atyr Pharma Inc

aTyr Pharma, Inc

aTyr Pharma is trending as traders anticipate the release of Phase 3 trial data for their lead drug, Efzofitimod, with potential implications for treating pulmonary sarcoidosis; the community is discussing possible outcomes and speculating on a short squeeze, while acknowledging the inherent risks of a binary biotech event; some are closely watching for early data leaks or unusual trading patterns, while others are reviewing past trial data and KOL opinions to inform their investment decisions.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Asset Entities Inc - Ordinary Shares - Class B

Asset Entities Inc.

Asset Entities Inc. ($ASST) is trending due to its recent merger with Strive and a strategic shift towards Bitcoin, sparking discussions of a potential short squeeze. The community is focused on high short interest, borrow fees, and the possibility of forced buy-ins, with many anticipating significant price movement. Some traders are experiencing trading restrictions, while others speculate on the impact of potential dilution from warrants.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is surging amid discussions of potential Q3 delivery beats and optimism surrounding future growth areas like robotics and energy storage. Community discussions also highlight Barclays' expectations for delivery growth and debates over the impact of expiring EV credits. Technical analysis suggests a breakout, though some investors remain cautious, citing valuation concerns and potential pullbacks.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending as investors discuss its high short interest and potential for a squeeze, with some citing the upcoming Rumble Wallet launch and the Northern Data acquisition as possible catalysts. JD Vance's exclusive on the platform and overall ties to prominent figures are also fueling community speculation. Despite some frustration with the stock's performance, bulls remain optimistic about its long-term potential, particularly with its connections to crypto and a shift towards alternative media.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending amid excitement surrounding upcoming presentations at the Quantum World Congress and UK regulatory approval for its acquisition of Oxford Ionics. The community is actively debating whether IONQ can achieve a market capitalization similar to that of NVDA, and many are citing the stock's potential for significant long-term gains while some discuss short-term profit taking.

mF International Ltd. is a holding company, which engages in the development and provision of financial trading solutions through its subsidiary. It offers real-time mission critical forex, bullion and commodities trading platform solutions, financial value-added services, mobile applications, and financial information for brokers and institutional clients via internet or platform as software as a service. The company was founded by Tai Wai Lam and Chi Weng Tam on June 15, 2022, and is headquartered in Hong Kong.

mF International Ltd - Ordinary Shares - Class A

mF International Ltd

mF International ($MFI) is trending due to community excitement around its low float and potential for a significant surge, drawing comparisons to other stocks with similar patterns. Traders are actively discussing a potential reverse merger with a crypto infrastructure play and the possibility of MFI becoming a major player in the crypto space. The company's recent SEC filing, which includes a $700M mixed shelf offering, has further fueled speculation and bullish sentiment.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is seeing increased discussion around its price action and future potential, with some traders expressing frustration over its failure to rally despite positive developments in the broader crypto market. Community members are debating potential catalysts, including upcoming announcements and the impact of macro events like rate cuts, while others are highly critical, citing concerns about its leadership and long-term viability. The conversation is further polarized by perspectives on technical analysis and the influence of leveraged trading on its price.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending due to positive sentiment around nuclear energy deals and potential entry into the US SMR market. Community members are discussing the UK's commitment to nuclear expansion and anticipating further news from upcoming industry events. Increased defense spending and potential partnerships related to AI data centers are also driving interest in the stock.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

UBS⬆️the PT on $ACAD to $32 from $22 and reiterated at a Buy rating: 
 
&quot;We have become incrementally more positive on the Acadia thesis since the current CEO took the helm, making significant strides on multiple fronts: 
1) Daybue has started to stabilize, 
2) Nuplazid IP got extended &amp; 
3) pipeline diversification has started to work out. 
 
Further, mgmt&#39;s confidence around putting long-term guide can continue to drive investor excitement from 
here. 
 
We note that multiple SMID-biotech stocks such as $HZNP, $ITCI, $BPMC, $BIVV outperformed in quarters/year after establishing peak sales guidance for the business. 
 
$ACAD mgmt outlined: 
a) potential peak NUPLAZID/DAYBUE sales of $1.5-2.0b, 
b) risk adj peak sales of $2.5b for pipeline assets, with full peak sales potential of $12b. 
 
In our view, the stock could potentially generate significant upside on the upcoming PWS read-out in early 4Q25.&quot;

Carla Sylvester

RBC Capital, on June 23,⬆️the PT on $ACAD to $38 from $26 and reiterated at an Outperform 
$AZN $NVS $AXSM PTCT RARE JAZZ 
$SLNO RYTM AARD 
RBC Capital said in its note, &quot; $ACAD represents a solid commercial-stage story with an emerging pipeline, with a meaningful recent Nuplazid IP win providing a high likelihood of cash flow sustainability and commercial tailwinds of late suggesting some continued Nuplazid growth and Daybue stabilization prospects. 
 
Maturing commercial franchises, exposure to macro/policy issues (IRA, MFN), and higher risk to the next pipeline catalyst (&#39;101 for PWS) add some complexity to the setup, but with the scarcity value of $1B + annual revenue from existing products now likely sustainable well into the next decade and at a &lt;$4B cap, stock looks fundamentally undervalued and any pipeline contribution is likely all upside.&quot;

StockTwits Web

Acadia Pharmaceuticals Inc

AstraZeneca PLC

Novartis AG

Axsome Therapeutics Inc

Soleno Therapeutics Inc

Quantumup

Horizon Therapeutics Plc

Intra-Cellular Therapies Inc

Blueprint Medicines Corp

Bioverativ Inc

 to $32 from $22 and reiterated at a Buy rating: 
 
"We have become incrementally more positive on the Acadia thesis since the current CEO took the helm, making significant strides on multiple fronts: 
1) Daybue has started to stabilize, 
2) Nuplazid IP got extended & 
3) pipeline diversification has started to work out. 
 
Further, mgmt's confidence around putting long-term guide can continue to drive investor excitement from 
here. 
 
We note that multiple SMID-biotech stocks such as 

 outperformed in quarters/year after establishing peak sales guidance for the business. 
 


 mgmt outlined: 
a) potential peak NUPLAZID/DAYBUE sales of $1.5-2.0b, 
b) risk adj peak sales of $2.5b for pipeline assets, with full peak sales potential of $12b. 
 
In our view, the stock could potentially generate significant upside on the upcoming PWS read-out in early 4Q25."